BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)
BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)
Biologics Contract Manufacturing Market, By Service Type (Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing, Drug product/Formulation and Fill-Finish (FDF), Analytical and Quality Control services, Process development and scale-up/Technology transfer, and Packaging, labeling and ancillary services), By Biologic Type (Monoclonal antibodies (mAbs), Recombinant proteins and enzymes, Vaccines, Cell and gene therapies, Antibody-drug conjugates (ADCs), and Others (growth factors, cytokines, fusion proteins)), By Production System (Mammalian systems (CHO, NS0, HEK), Microbial systems (E. coli, yeast), and Alternative/Emerging systems (insect cells, plant, cell-free)), By Scale (Preclinical/clinical scale manufacturing and Commercial scale manufacturing), By Company Size (Small to Mid-sized Contract Manufacturers and Large Contract Manufacturing Organizations (CMOs/CDMOs)), By Therapeutic Area (Oncology/Hematology, Immunology and Autoimmune Disorders, Infectious Diseases and Vaccinology, Cardiovascular and Renal Disorders, Neurology and Central Nervous System (CNS) Disorders, Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid), Respiratory Disorders, and Others (Dermatology, Rare and Orphan Diseases)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
- Published In: 25 Sep, 2025
- Code: CMI8662
- Pages: 168
- Formats: Excel and PDF
- Industry: Biotechnology
-
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032
The global biologics contract manufacturing market is estimated to be valued at USD 35.91 Bn in 2025 and is expected to reach USD 71.78 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032. The global biologics contract manufacturing market represents a critical segment of the pharmaceutical outsourcing industry, encompassing specialized manufacturing services for complex biological products including monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins. This market has emerged as a strategic solution for pharmaceutical and biotechnology companies seeking to leverage external expertise, advanced manufacturing capabilities, and regulatory compliance while optimizing operational costs and accelerating time-to-market for life-saving therapies.
Contract manufacturing organizations (CMOs) in this space provide comprehensive services ranging from process development and scale-up to commercial manufacturing, quality control, and regulatory support. The increasing complexity of biological products, coupled with stringent regulatory requirements and substantial capital investments required for state-of-the-art manufacturing facilities, has driven the adoption of outsourcing strategies among both established pharmaceutical giants and emerging biotech companies. The market encompasses various therapeutic areas including oncology, autoimmune diseases, infectious diseases, and rare disorders, with manufacturing services spanning from early-phase clinical trial materials to large-scale commercial production, making it an indispensable component of the modern biopharmaceutical value chain.
Market Dynamics
The global biologics contract manufacturing market is propelled by several compelling drivers, primarily the exponential growth in biologics pipeline development, with over 7,000 biologics currently in various stages of clinical development worldwide, creating unprecedented demand for specialized manufacturing capacity. The increasing complexity of biological products, particularly advanced therapies like CAR-T cell therapies and gene therapies, requires sophisticated manufacturing expertise that many companies prefer to outsource rather than develop in-house. Rising development costs, which can exceed USD 2.6 billion per approved drug, coupled with the need for specialized facilities, equipment, and regulatory expertise, make contract manufacturing an attractive cost-optimization strategy.
Additionally, the growing prevalence of chronic diseases and aging global population continues to drive demand for biologic treatments. However, the market faces significant restraints including stringent regulatory requirements that can create compliance challenges and delays, quality control complexities that can impact product consistency and safety, and supply chain vulnerabilities exposed during the COVID-19 pandemic. Intellectual property concerns and technology transfer challenges also pose barriers to outsourcing decisions. Despite these challenges, substantial opportunities emerge from the expanding biosimilars market, which requires cost-effective manufacturing solutions, increasing demand for personalized medicine and cell-based therapies, growing biopharmaceutical activities in emerging markets, and technological advancements in continuous manufacturing and single-use technologies that enhance efficiency and flexibility in biologics production.
Key Features of the Study
- This report provides in-depth analysis of the global biologics contract manufacturing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global biologics contract manufacturing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics, WuXi Biologics, Boehringer Ingelheim BioXcellence, Fujifilm Diosynth Biotechnologies, AGC Biologics, Recipharm, Siegfried, Rentschler Biopharma, Abzena, Charles River Laboratories, IDT Biologika, and Avid Bioservices
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global biologics contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics contract manufacturing market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing
- Drug product/Formulation and Fill-Finish (FDF)
- Analytical and Quality Control services
- Process development and scale-up/Technology transfer
- Packaging, labeling and ancillary services
- Biologic Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal antibodies (mAbs)
- Recombinant proteins and enzymes
- Vaccines
- Cell and gene therapies
- Antibody-drug conjugates (ADCs)
- Others (growth factors, cytokines, fusion proteins)
- Production System Insights (Revenue, USD Bn, 2020 - 2032)
- Mammalian systems (CHO, NS0, HEK)
- Microbial systems (E. coli, yeast)
- Alternative/Emerging systems (insect cells, plant, cell-free)
- Scale Insights (Revenue, USD Bn, 2020 - 2032)
- Preclinical/clinical scale manufacturing
- Commercial scale manufacturing
- Company Size Insights (Revenue, USD Bn, 2020 - 2032)
- Small to Mid-sized Contract Manufacturers
- Large Contract Manufacturing Organizations (CMOs/CDMOs)
- Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology/Hematology
- Immunology and Autoimmune Disorders
- Infectious Diseases and Vaccinology
- Cardiovascular and Renal Disorders
- Neurology and Central Nervous System (CNS) Disorders
- Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid)
- Respiratory Disorders
- Others (Dermatology, Rare and Orphan Diseases)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- North America
- Key Players Insights
- Lonza
- Thermo Fisher Scientific
- Catalent
- Samsung Biologics
- WuXi Biologics
- Boehringer Ingelheim BioXcellence
- Fujifilm Diosynth Biotechnologies
- AGC Biologics
- Recipharm
- Siegfried
- Rentschler Biopharma
- Abzena
- Charles River Laboratories
- IDT Biologika
- Avid Bioservices
Table of Contents
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biologics Contract Manufacturing Market, By Service Type
- Global Biologics Contract Manufacturing Market, By Biologic Type
- Global Biologics Contract Manufacturing Market, By Production System
- Global Biologics Contract Manufacturing Market, By Scale
- Global Biologics Contract Manufacturing Market, By Company Size
- Global Biologics Contract Manufacturing Market, By Therapeutic Area
- Global Biologics Contract Manufacturing Market, By Region
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Biologics Contract Manufacturing Market, By Service Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug product/Formulation and Fill-Finish (FDF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analytical and Quality Control services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Process development and scale-up/Technology transfer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Packaging, labeling and ancillary services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Introduction
Global Biologics Contract Manufacturing Market, By Biologic Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Monoclonal antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant proteins and enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell and gene therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antibody-drug conjugates (ADCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (growth factors, cytokines, fusion proteins)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Introduction
Global Biologics Contract Manufacturing Market, By Production System, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Mammalian systems (CHO, NS0, HEK)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microbial systems (E. coli, yeast)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Alternative/Emerging systems (insect cells, plant, cell-free)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Introduction
Global Biologics Contract Manufacturing Market, By Scale, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Preclinical/clinical scale manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Commercial scale manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Introduction
Global Biologics Contract Manufacturing Market, By Company Size, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Small to Mid-sized Contract Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Large Contract Manufacturing Organizations (CMOs/CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Introduction
Global Biologics Contract Manufacturing Market, By Therapeutic Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology/Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology and Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases and Vaccinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular and Renal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology and Central Nervous System (CNS) Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Dermatology, Rare and Orphan Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Introduction
Global Biologics Contract Manufacturing Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Biologic Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Company Size, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Biologic Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Company Size, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Biologic Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Company Size, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Biologic Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Company Size, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Biologic Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Company Size, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Biologic Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Company Size, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
- Introduction
Competitive Landscape
- Lonza
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Catalent
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Samsung Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim BioXcellence
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Recipharm
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siegfried
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rentschler Biopharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abzena
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDT Biologika
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Avid Bioservices
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About Us
*Browse 32 market data tables and 28 figures on 'Biologics Contract Manufacturing Market' - Global forecast to 2032
-
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
